Filing
2nd Quarter - Report
Lobbying activity
1
Inflation Reduction Act, Intellectual Property, Most Favored Nations Drug Pricing, Medicare Part D, Medicaid, Pharmaceutical Manufacturing
Inflation Reduction Act, Intellectual Property, Most Favored Nations Drug Pricing, Medicare Part D, Medicaid, Pharmaceutical Manufacturing